RU2012128541A - Применение 2,3-дигидроксипропилдодеканоата для лечения себореи - Google Patents
Применение 2,3-дигидроксипропилдодеканоата для лечения себореи Download PDFInfo
- Publication number
- RU2012128541A RU2012128541A RU2012128541/15A RU2012128541A RU2012128541A RU 2012128541 A RU2012128541 A RU 2012128541A RU 2012128541/15 A RU2012128541/15 A RU 2012128541/15A RU 2012128541 A RU2012128541 A RU 2012128541A RU 2012128541 A RU2012128541 A RU 2012128541A
- Authority
- RU
- Russia
- Prior art keywords
- seborrhea
- seborrheic
- composition
- composition according
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/08—Mineral waters; Sea water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
1. Применение 2,3-дигидроксипропилдодеканоата для лечения себореи.2. Применение по п.1, отличающееся тем, что себорея представляет собой себорею кожи.3. Применение по п.1, отличающееся тем, что себорея представляет собой себорею кожи головы.4. Применение по п.3 для замедления выпадения волос.5. Противосеборейная композиция, содержащая 2,3-дигидроксипропилдодеканоат, для лечения себореи.6. Противосеборейная композиция по п.5, отличающаяся тем, что себорея представляет собой себорею кожи.7. Противосеборейная композиция по п.5, отличающаяся тем, что себорея представляет собой себорею кожи головы.8. Противосеборейная композиция по п.5, отличающаяся тем, что содержит от 0,01 до 20 мас.%, предпочтительно от 0,5 до 10 мас.%, более предпочтительно от 1 до 5 мас.% 2,3-дигидроксипропилдодеканоата по отношению к общей массе композиции.9. Противосеборейная композиция по любому из пп.5-8, отличающаяся тем, что содержит 2,3-дигидроксипропилдодеканоат в качестве единственного активного ингредиента.10. Противосеборейная композиция по любому из пп.5-8, отличающаяся тем, что содержит термальную воду Avène.11. Противосеборейная композиция по п.8, отличающаяся тем, что содержит 2,3-дигидроксипропилдодеканоат, термальную воду Avène и косметически приемлемый носитель.12. Способ косметического лечения себореи, включающий нанесение на кожу или кожу головы косметической композиции, охарактеризованной в любом из пп.5-11.
Claims (12)
1. Применение 2,3-дигидроксипропилдодеканоата для лечения себореи.
2. Применение по п.1, отличающееся тем, что себорея представляет собой себорею кожи.
3. Применение по п.1, отличающееся тем, что себорея представляет собой себорею кожи головы.
4. Применение по п.3 для замедления выпадения волос.
5. Противосеборейная композиция, содержащая 2,3-дигидроксипропилдодеканоат, для лечения себореи.
6. Противосеборейная композиция по п.5, отличающаяся тем, что себорея представляет собой себорею кожи.
7. Противосеборейная композиция по п.5, отличающаяся тем, что себорея представляет собой себорею кожи головы.
8. Противосеборейная композиция по п.5, отличающаяся тем, что содержит от 0,01 до 20 мас.%, предпочтительно от 0,5 до 10 мас.%, более предпочтительно от 1 до 5 мас.% 2,3-дигидроксипропилдодеканоата по отношению к общей массе композиции.
9. Противосеборейная композиция по любому из пп.5-8, отличающаяся тем, что содержит 2,3-дигидроксипропилдодеканоат в качестве единственного активного ингредиента.
10. Противосеборейная композиция по любому из пп.5-8, отличающаяся тем, что содержит термальную воду Avène.
11. Противосеборейная композиция по п.8, отличающаяся тем, что содержит 2,3-дигидроксипропилдодеканоат, термальную воду Avène и косметически приемлемый носитель.
12. Способ косметического лечения себореи, включающий нанесение на кожу или кожу головы косметической композиции, охарактеризованной в любом из пп.5-11.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0959165A FR2954124B1 (fr) | 2009-12-18 | 2009-12-18 | Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee |
| FR0959165 | 2009-12-18 | ||
| PCT/EP2010/070028 WO2011073370A2 (fr) | 2009-12-18 | 2010-12-17 | Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2012128541A true RU2012128541A (ru) | 2014-01-27 |
| RU2568833C2 RU2568833C2 (ru) | 2015-11-20 |
Family
ID=42358115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012128541/15A RU2568833C2 (ru) | 2009-12-18 | 2010-12-17 | Применение 2,3-дигидроксипропилдодеканоата для лечения себореи |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9101785B2 (ru) |
| EP (1) | EP2512420B1 (ru) |
| JP (1) | JP6129557B2 (ru) |
| KR (1) | KR101774608B1 (ru) |
| CN (2) | CN106063768A (ru) |
| AU (1) | AU2010332759B2 (ru) |
| BR (1) | BR112012014658A2 (ru) |
| CA (1) | CA2784542C (ru) |
| ES (1) | ES2757816T3 (ru) |
| FR (1) | FR2954124B1 (ru) |
| GE (1) | GEP20146170B (ru) |
| IL (1) | IL220423A (ru) |
| MA (1) | MA33842B1 (ru) |
| MX (1) | MX338441B (ru) |
| NZ (1) | NZ601279A (ru) |
| PT (1) | PT2512420T (ru) |
| RU (1) | RU2568833C2 (ru) |
| TN (1) | TN2012000301A1 (ru) |
| UA (1) | UA110332C2 (ru) |
| WO (1) | WO2011073370A2 (ru) |
| ZA (1) | ZA201204287B (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120016980A (ko) | 2010-08-17 | 2012-02-27 | 한국전자통신연구원 | 영상 부호화 방법 및 장치, 그리고 복호화 방법 및 장치 |
| FR2983858B1 (fr) * | 2011-12-08 | 2014-01-03 | Fabre Pierre Dermo Cosmetique | Nouveaux composes inhibiteurs de la lipogenese |
| FR2992859B1 (fr) | 2012-07-09 | 2014-10-03 | Fabre Pierre Dermo Cosmetique | Utilisation de coceth sulfate de zinc comme agent antibacterien vis a vis de propionibacterium acnes |
| US20170165158A1 (en) * | 2014-06-24 | 2017-06-15 | Conopco, Inc., D/B/A Unilever | Hair treatment composition |
| WO2018125694A1 (en) * | 2017-01-01 | 2018-07-05 | Khalifa University of Science and Technology | Compositions from halophyte plants and methods of use thereof |
| IT201800002843A1 (it) | 2018-02-20 | 2019-08-20 | Idi Farm S R L | Composizione per l’uso nel trattamento della dermatite seborroica |
| KR20230132799A (ko) * | 2021-01-29 | 2023-09-18 | 삐에르화브르데르모-코스메띠끄 | 여드름 민감성 피부의 일상 관리에 유용한 국소 조성물 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3740186A1 (de) * | 1987-06-24 | 1989-01-05 | Beiersdorf Ag | Desodorierende und antimikrobielle zusammensetzung zur verwendung in kosmetischen oder topischen zubereitungen |
| US5057501A (en) * | 1990-03-13 | 1991-10-15 | Dermatologic Research Corporation | Methods for treatment of papulosquamous and eczematous diseases |
| SE500777C2 (sv) * | 1992-04-14 | 1994-08-29 | Hydro Pharma Ab | Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav |
| TW382595B (en) * | 1993-10-15 | 2000-02-21 | Merck & Co Inc | Pharmaceutical composition for use in arresting and reversing androgenic alopecia |
| US5547957A (en) * | 1993-10-15 | 1996-08-20 | Merck & Co., Inc. | Method of treating androgenic alopecia with 5-α reductase inhibitors |
| IL110943A (en) * | 1994-09-13 | 1997-02-18 | Univ Ramot | Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders |
| FR2731615B1 (fr) * | 1995-03-15 | 1997-07-25 | Fabre Pierre Dermo Cosmetique | Compositions ecran-solaire comprenant un melange de particules d'oxyde de titane et/ou de zinc, leur procede de preparation et leur utilisation |
| ZA962455B (en) * | 1995-03-31 | 1996-10-02 | B Eugene Guthery | Fast acting and persistent topical antiseptic |
| US6696484B2 (en) * | 1997-10-31 | 2004-02-24 | University Of Chicago Office Of Technology And Intellectual Property | Method and compositions for regulation of 5-alpha reductase activity |
| ITMI20011732A1 (it) * | 2001-08-07 | 2003-02-07 | Indena Spa | Composizioni farmaceutiche e/o cosmetiche orali per il trattamento e la prevenzione di disturbi del cuoio capelluto |
| ITBS20010111A1 (it) * | 2001-12-20 | 2003-06-20 | Paoli Ambrosi Gianfranco De | Composizione per uso topico a base dell'estere etilico dell'acido linoleico e e del trietil estere dell'acido citrico associati con opportun |
| KR100564386B1 (ko) * | 2002-05-13 | 2006-03-27 | 주식회사 마이코플러스 | 4-하이드록시-5-메톡시-4-[2-메틸-3-(3-메틸-2-부테닐)-2-옥시란닐]-1-옥사스피로[2,5]옥탄-6-온을 함유한 지루치료용 약제학적 조성물 |
| JP2005040403A (ja) * | 2003-07-23 | 2005-02-17 | Shiseido Co Ltd | 敏感肌のための美容施術方法 |
| WO2005079164A2 (ja) * | 2004-02-10 | 2005-09-01 | Kyushu Tlo Co Ltd | ５α−リダクターゼ阻害剤 |
| FR2867973A1 (fr) * | 2004-03-26 | 2005-09-30 | B Prince Sarl Lab | Composition de soin capillaire contenant du sabal |
| EP1859774A4 (en) * | 2005-02-22 | 2009-09-30 | Maruzen Pharm Co Ltd | CAPILLARY COSMETICS |
| US20090203628A1 (en) * | 2008-02-12 | 2009-08-13 | Jan Marini | Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition |
-
2009
- 2009-12-18 FR FR0959165A patent/FR2954124B1/fr active Active
-
2010
- 2010-12-17 RU RU2012128541/15A patent/RU2568833C2/ru active
- 2010-12-17 UA UAA201208843A patent/UA110332C2/ru unknown
- 2010-12-17 AU AU2010332759A patent/AU2010332759B2/en active Active
- 2010-12-17 JP JP2012543777A patent/JP6129557B2/ja active Active
- 2010-12-17 MX MX2012007142A patent/MX338441B/es active IP Right Grant
- 2010-12-17 PT PT107929333T patent/PT2512420T/pt unknown
- 2010-12-17 BR BR112012014658A patent/BR112012014658A2/pt not_active Application Discontinuation
- 2010-12-17 CN CN201610511468.6A patent/CN106063768A/zh active Pending
- 2010-12-17 WO PCT/EP2010/070028 patent/WO2011073370A2/fr not_active Ceased
- 2010-12-17 GE GEAP201012797A patent/GEP20146170B/en unknown
- 2010-12-17 CN CN2010800570221A patent/CN102781415A/zh active Pending
- 2010-12-17 CA CA2784542A patent/CA2784542C/fr active Active
- 2010-12-17 KR KR1020127016196A patent/KR101774608B1/ko active Active
- 2010-12-17 US US13/516,347 patent/US9101785B2/en active Active
- 2010-12-17 NZ NZ601279A patent/NZ601279A/en unknown
- 2010-12-17 EP EP10792933.3A patent/EP2512420B1/fr active Active
- 2010-12-17 ES ES10792933T patent/ES2757816T3/es active Active
-
2012
- 2012-06-12 ZA ZA2012/04287A patent/ZA201204287B/en unknown
- 2012-06-14 TN TNP2012000301A patent/TN2012000301A1/fr unknown
- 2012-06-14 IL IL220423A patent/IL220423A/en active IP Right Grant
- 2012-06-25 MA MA34997A patent/MA33842B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL220423A (en) | 2016-04-21 |
| CN106063768A (zh) | 2016-11-02 |
| AU2010332759A1 (en) | 2012-08-09 |
| JP6129557B2 (ja) | 2017-05-17 |
| RU2568833C2 (ru) | 2015-11-20 |
| CA2784542A1 (fr) | 2011-06-23 |
| KR101774608B1 (ko) | 2017-09-04 |
| JP2013514328A (ja) | 2013-04-25 |
| WO2011073370A2 (fr) | 2011-06-23 |
| BR112012014658A2 (pt) | 2016-04-05 |
| ES2757816T3 (es) | 2020-04-30 |
| MX2012007142A (es) | 2012-07-03 |
| PT2512420T (pt) | 2019-12-13 |
| MX338441B (es) | 2016-04-14 |
| MA33842B1 (fr) | 2012-12-03 |
| US20120258065A1 (en) | 2012-10-11 |
| EP2512420B1 (fr) | 2019-09-04 |
| TN2012000301A1 (fr) | 2013-12-12 |
| GEP20146170B (en) | 2014-09-25 |
| CN102781415A (zh) | 2012-11-14 |
| US9101785B2 (en) | 2015-08-11 |
| EP2512420A2 (fr) | 2012-10-24 |
| FR2954124A1 (fr) | 2011-06-24 |
| UA110332C2 (en) | 2015-12-25 |
| WO2011073370A3 (fr) | 2012-07-19 |
| NZ601279A (en) | 2015-02-27 |
| ZA201204287B (en) | 2013-05-29 |
| AU2010332759B2 (en) | 2015-04-16 |
| CA2784542C (fr) | 2018-07-17 |
| FR2954124B1 (fr) | 2012-04-06 |
| KR20120094501A (ko) | 2012-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201021937D0 (en) | Skin sanitizer compositions comprising alcohol based emulsion | |
| WO2012068515A3 (en) | Compositions and methods for hair growth | |
| MX2010001122A (es) | Composiciones bloqueadoras de sol de rociado continuo. | |
| BR112013004914A2 (pt) | "composições de pele e métodos de uso das mesmas". | |
| EP2739155A4 (en) | SKIN CARE WITH COMBINATIONS OF NATURAL INGREDIENTS | |
| WO2010104301A3 (en) | Cosmetic composition for skin moisturizing | |
| EA202092820A1 (ru) | Композиция для расслабления мышц | |
| NZ601279A (en) | Use of 2,3-dihydroxypropyl dodecanoate for treating seborrhea | |
| MX2015006313A (es) | Composicion simbiotica y el uso de la misma. | |
| FR2997299B1 (fr) | Association d'extraits de plantes, ingredient actif cosmetique et composition les contenant, et utilisation topique cosmetique | |
| JP2013514328A5 (ru) | ||
| WO2014009862A3 (en) | Cosmetic composition comprising benzylsulfonyl-d-ser-homophe-(4-amidino-benzylamide) and a polyalcohol | |
| RU2013112008A (ru) | Композиции, содержащие павловнин и/или экстракты павловнии, и их использование | |
| GB2489173A (en) | Multipurpose boat | |
| FR2935379B1 (fr) | Utilisation de n-acyl aminoacides comme principe actifs cosmetiques et pharmaceutiques, regulateurs de la proportion de keratinocytes basaux de l'epiderme de la peau humaine exprimant la forme nucleaire de la survivine ; compositions | |
| WO2011062441A3 (ko) | 미용조성물용 갈조류분말제조방법, 상기 방법으로 제조된 미용조성물용 갈조류분말, 상기 갈조류분말함유 비누조성물 및 상기 비누조성물을 포함하는 화장용 비누 | |
| RU2016105308A (ru) | Композиция, содержащая экстракт комбинации растений, состоящей из acanthopanax koreanum nakai и crinum asiaticum var. japonicum, предотвращающая выпадение волос и стимулирующая рост волос | |
| DE602004004958D1 (de) | Biphasiches Mittel und dessen Verwendungen in Kosmetika | |
| EP2606934A3 (de) | Verwendung von Octanohydroxamsäure in Haarstylingformulierungen | |
| EA202090437A1 (ru) | Синергетическая композиция в качестве промотора аутофагии | |
| KR20090099164A (ko) | 블랙 머드를 함유하는 퍼머넌트 조성물 | |
| WO2011079971A3 (de) | Kosmetische mittel, enthaltend euk-134 und/oder euk-118 und mindestens einen pflegestoff | |
| WO2012055665A3 (de) | Mittel für keratinhaltige fasern | |
| FR2947449B1 (fr) | Utilisations cosmetiques d'un derive d'acide jasmonique pour la protection anti-oxydante naturelle de la peau, pour le traitement des cheveux et du cuir chevelu | |
| RU2006124239A (ru) | Составы для применения на коже |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HE9A | Changing address for correspondence with an applicant |